Esha Jain
Esha Jain
The Broad Institute , Dana Farber Cancer Institute
Подтвержден адрес электронной почты в домене broadinstitute.org
Название
Процитировано
Процитировано
Год
Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia
DB Sykes, YS Kfoury, FE Mercier, MJ Wawer, JM Law, MK Haynes, ...
Cell 167 (1), 171-186. e15, 2016
2452016
SIRT6 suppresses pancreatic cancer through control of Lin28b
S Kugel, C Sebastián, J Fitamant, KN Ross, SK Saha, E Jain, A Gladden, ...
Cell 165 (6), 1401-1415, 2016
1722016
Prevalence and mutational determinants of high tumor mutation burden in breast cancer
R Barroso-Sousa, E Jain, O Cohen, D Kim, J Buendia-Buendia, E Winer, ...
Annals of Oncology 31 (3), 387-394, 2020
79*2020
The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research
CA Painter, E Jain, BN Tomson, M Dunphy, RE Stoddard, BS Thomas, ...
Nature medicine 26 (2), 181-187, 2020
632020
Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer
Clinical Cancer Research 26 (11), 2565-2572, 2020
572020
A specialized mechanism of translation mediated by FXR1a-associated microRNP in cellular quiescence
SIA Bukhari, SS Truesdell, S Lee, S Kollu, A Classon, M Boukhali, E Jain, ...
Molecular cell 61 (5), 760-773, 2016
452016
Single-cell transcriptional analysis of normal, aberrant, and malignant hematopoiesis in zebrafishSingle-cell analysis in zebrafish hematopoiesis
FE Moore, EG Garcia, R Lobbardi, E Jain, Q Tang, JC Moore, M Cortes, ...
The Journal of experimental medicine 213 (6), 979-992, 2016
432016
TOX regulates growth, DNA repair, and genomic instability in T-cell acute lymphoblastic leukemia
R Lobbardi, J Pinder, B Martinez-Pastor, M Theodorou, JS Blackburn, ...
Cancer discovery 7 (11), 1336-1353, 2017
322017
Building and analysis of protein-protein interactions related to diabetes mellitus using support vector machine, biomedical text mining and network analysis
R Vyas, S Bapat, E Jain, M Karthikeyan, S Tambe, BD Kulkarni
Computational biology and chemistry 65, 37-44, 2016
252016
The Metastatic Breast Cancer (MBC) project: Accelerating translational research through direct patient engagement.
N Wagle, C Painter, E Anastasio, M Dunphy, M McGillicuddy, D Kim, ...
Journal of Clinical Oncology 35 (15_suppl), 1076-1076, 2017
102017
Genomic characterization of de novo metastatic breast cancer
AC Garrido-Castro, LF Spurr, ME Hughes, YY Li, AD Cherniack, P Kumari, ...
Clinical Cancer Research 27 (4), 1105-1118, 2021
82021
A study of applications of machine learning based classification methods for virtual screening of lead molecules
R Vyas, S Bapat, E Jain, S S Tambe, M Karthikeyan, B D Kulkarni
Combinatorial chemistry & high throughput screening 18 (7), 658-672, 2015
82015
Abstract B085: High mutation burden and response to immune checkpoint inhibitors in angiosarcomas of the scalp and face
C Painter, E Jain, M Dunphy, E Anastasio, M McGillicuddy, R Stoddard, ...
Cancer Immunology Research 7 (2 Supplement), B085-B085, 2019
22019
The Metastatic Breast Cancer Project: Partnering with patients to accelerate progress in cancer research
N Wagle, C Painter, E Anastasio, M Dunphy, M McGillicuddy, R Stoddard, ...
Cancer Research 78 (13 Supplement), 5371-5371, 2018
22018
Count me in: A patient-driven research initiative to accelerate cancer research.
N Wagle, C Painter, EM Van Allen, AJ Bass, E Anastasio, M Dunphy, ...
Journal of Clinical Oncology 36 (15_suppl), e13501-e13501, 2018
22018
Characterization of mutational processes in ER+ metastatic breast cancer.
J Buendia-Buendia, O Cohen, D Kim, E Jain, EP Winer, NU Lin, N Wagle
Journal of Clinical Oncology 37 (15_suppl), 1019-1019, 2019
12019
Abstract PD9-02: Evolutionary analysis of 462 serial metastatic biopsies from 208 patients with estrogen receptor-positive (ER+) metastatic breast cancer (MBC) using whole …
O Cohen, J Buendia-Buendia, S Wander, U Nayar, P Mao, A Waks, D Kim, ...
Cancer Research 79 (4 Supplement), PD9-02-PD9-02, 2019
12019
Abstract PD9-03: The genomic landscape of de novo metastatic breast cancer (MBC)
E Jain, D Kim, JB Buendia, O Cohen, RB Sousa, E Anastasio, M Dunphy, ...
Cancer Research 79 (4 Supplement), PD9-03-PD9-03, 2019
12019
The Angiosarcoma Project: Generating the genomic landscape of an exceedingly rare cancer through a nationwide patient-driven initiative
M Dunphy, E Jain, E Anastasio, M McGillicuddy, R Stoddard, B Thomas, ...
Cancer Research 78 (13 Supplement), 5384-5384, 2018
12018
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women …
SM Balch, I Vaz-Luis, T Li, N Tayob, E Jain, K Helvie, ...
Breast Cancer Research and Treatment 189 (2), 411-423, 2021
2021
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20